Cargando…
Erratum to: JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
Autores principales: | Li, Li-Liang, Xue, Ai-Min, Li, Bei-Xu, Shen, Yi-Wen, Li, Yu-Hua, Luo, Cheng-Liang, Zhang, Ming-Chang, Jiang, Jie-Qing, Xu, Zu-De, Xie, Jian-Hui, Zhao, Zi-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116818/ https://www.ncbi.nlm.nih.gov/pubmed/27871311 http://dx.doi.org/10.1186/s13058-016-0776-3 |
Ejemplares similares
-
JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
por: Li, Li-Liang, et al.
Publicado: (2014) -
ARHI is a novel epigenetic silenced tumor suppressor in sporadic pheochromocytoma
por: Wang, Dong, et al.
Publicado: (2017) -
Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
por: Lee, Yi Fang, et al.
Publicado: (2017) -
Erratum to: Repression of chimeric transcripts emanating from endogenous retrotransposons by a sequence-specific transcription factor
por: Mak, Ka Sin, et al.
Publicado: (2016) -
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum
por: Dong, Jiang-Kai, et al.
Publicado: (2021)